Pancreatic Cancer Research

ResearcherAlbert Einstein College of MedicineActive in the last 2 years

Chandan Guha

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1906-2186; OpenAlex author ID A5055510159; NIH RePORTER profile ID 7274991. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
1
Labs led
1
Collaborators
28
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 2 papers · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 grant · 2026: 1 paper

Papers 6

  1. High SMAD4 Expression is Associated With Improved Clinical Outcomes in Patients With Resectable Pancreatic Cancer: An Analysis of NRG Oncology/RTOG 9704. Co-author DOI 10.1016/j.ijrobp.2026.09.014↗
  2. Evaluating dosimetric constraints for carbon ion radiotherapy in the treatment of locally advanced pancreatic cancer. Co-author DOI 10.1186/s13014-020-01515-5↗
  3. Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG … Co-author DOI 10.1002/cncr.31058↗
  4. RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy… Co-author DOI 10.1016/j.ijrobp.2015.10.062↗
  5. Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway Approach. Co-author DOI 10.1097/mpa.0000000000000710↗
  6. Cytidine deaminase single-nucleotide polymorphism is predictive of toxicity from gemcitabine in patients with pancreatic cancer: RTOG 9704. Co-author DOI 10.1038/tpj.2011.22↗

Grants 1

  1. Relative Immunological Effectiveness (RIE) of Carbon Ion Radiation Therapy for Pancreatic Cancer R01CA257509↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaodong Wu · 1 shared grant, 2025 · strength 1.07
  2. William F. Regine · 4 shared papers, 2016–2026 · strength 0.41
  3. Hyun Kim · 1 shared paper, 2026 · strength 0.24
  4. Edgar Ben‐Josef · 1 shared paper, 2026 · strength 0.24
  5. Ryan N. Robb · 1 shared paper, 2026 · strength 0.24
  6. Terence Marques Williams · 1 shared paper, 2026 · strength 0.24
  7. Lauren E. Henke · 1 shared paper, 2026 · strength 0.24
  8. Michael G. Haddock · 1 shared paper, 2026 · strength 0.24
  9. Christopher H. Crane · 2 shared papers, 2016–2018 · strength 0.12
  10. Lien-Chun Lin · 1 shared paper, 2020 · strength 0.12
  11. Guo-Liang Jiang · 1 shared paper, 2020 · strength 0.12
  12. Xiaodong Wu · 1 shared paper, 2020 · strength 0.12
  13. Madhur Kumar Garg · 1 shared paper, 2020 · strength 0.12
  14. Adam Paul Dicker · 2 shared papers, 2012–2018 · strength 0.11
  15. Hany Elsaleh · 2 shared papers, 2012–2016 · strength 0.09
  16. Talia Golan · 1 shared paper, 2018 · strength 0.07
  17. Yaacov Richard Lawrence · 1 shared paper, 2018 · strength 0.07
  18. William C. Small · 1 shared paper, 2018 · strength 0.07
  19. John Parker Hoffman · 1 shared paper, 2016 · strength 0.05
  20. James L. Abbruzzese · 1 shared paper, 2016 · strength 0.05
  21. Ross Allen Abrams · 1 shared paper, 2016 · strength 0.05
  22. Ping Chang · 1 shared paper, 2016 · strength 0.05
  23. Howard P. Safran · 1 shared paper, 2016 · strength 0.05
  24. Donghui Li · 1 shared paper, 2016 · strength 0.05
  25. Xiyong Liu · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.